These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10573790)

  • 61. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis.
    Eller DA; Austin PF; Tanguay S; Homsy YL
    Eur Urol; 1998; 33 Suppl 3():25-9. PubMed ID: 9599733
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enuresis subtypes based on nocturnal hypercalciuria: a multicenter study.
    Aceto G; Penza R; Coccioli MS; Palumbo F; Cresta L; Cimador M; Chiozza ML; Caione P
    J Urol; 2003 Oct; 170(4 Pt 2):1670-3. PubMed ID: 14501688
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nocturnal enuresis: correction of renal function by desmopressin and diclofenac.
    Natochin YV; Kuznetsova AA
    Pediatr Nephrol; 2000 Jan; 14(1):42-7. PubMed ID: 10654330
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathophysiology and impact of nocturnal enuresis.
    Hjälmås K
    Acta Paediatr; 1997 Sep; 86(9):919-22. PubMed ID: 9343267
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Possible role of prostaglandins in pathogenesis of nocturnal enuresis in children.
    Kuznetsova AA; Shakhmatova EI; Prutskova NP; Natochin YV
    Scand J Urol Nephrol; 2000 Feb; 34(1):27-31. PubMed ID: 10757266
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Long-term treatment with desmopressin in children with primary nocturnal enuresis. An international multicenter study].
    Snajderová M; Lehotská V; Kocnarová N; Kernová T; Archmanová E; Anadolijska AK; Peterkova VA; Ulmeanu C; Lánská V; Janda P
    Cas Lek Cesk; 1999 Jul; 138(14):429-35. PubMed ID: 10566214
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis.
    Kamperis K; Van Herzeele C; Rittig S; Vande Walle J
    Pediatr Nephrol; 2017 Feb; 32(2):217-226. PubMed ID: 27071997
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis.
    Rushton HG; Belman AB; Zaontz MR; Skoog SJ; Sihelnik S
    J Urol; 1996 Aug; 156(2 Pt 2):651-5. PubMed ID: 8683752
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria.
    Chang YL; Lin AT; Chen KK
    J Urol; 2007 Jun; 177(6):2227-9; discussion 2230. PubMed ID: 17509326
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response.
    Evans JH; Meadow SR
    Arch Dis Child; 1992 Feb; 67(2):184-8. PubMed ID: 1543376
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Primary nocturnal enuresis in children. Background and treatment.
    Wille S
    Scand J Urol Nephrol Suppl; 1994; 156():1-48. PubMed ID: 7939438
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Desmopressin tablet treatment in nocturnal enuresis.
    Stenberg A; Läckgren G
    Scand J Urol Nephrol Suppl; 1995; 173():95-9. PubMed ID: 8719577
    [No Abstract]   [Full Text] [Related]  

  • 73. Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Swedish Enuresis Trial Group.
    Tullus K; Bergström R; Fosdal I; Winnergård I; Hjälmås K
    Acta Paediatr; 1999 Nov; 88(11):1274-8. PubMed ID: 10591433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effectiveness of desmopressin in the treatment of childhood nocturnal enuresis: predicting response using pretreatment variables.
    Butler R; Holland P; Devitt H; Hiley E; Roberts G; Redfern E
    Br J Urol; 1998 May; 81 Suppl 3():29-36. PubMed ID: 9634016
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

  • 76. First uninterrupted sleep period in children and adolescents with nocturnal enuresis: Added value in diagnosis and follow-up during therapy.
    Karamaria S; Dhondt K; Everaert K; Mauel R; Nørgaard JP; Raes A; Van Herzeele C; Verbakel I; Walle JV
    Neurourol Urodyn; 2024 Jun; 43(5):1147-1154. PubMed ID: 37929315
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe.
    Hjälmås K; Bengtsson B
    Clin Pediatr (Phila); 1993 Jul; Spec No():19-24. PubMed ID: 8039334
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ; Stokes A; Turner KL
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.